344 results on '"Bourdin, Arnaud"'
Search Results
2. Anti-IL-4R versus Anti-IL-5/5R after Anti-IL-5/5R failure in asthma: an emulated target trial
3. VJBM-2023-0014 Final
4. VJBM-2023-0014 Final
5. Hospitalizations for Chronic Obstructive Pulmonary Disease Exacerbation During COVID-19
6. Altered skeletal muscle function and beneficial effects of exercise training in a rat model of induced pulmonary emphysema
7. The HHIP gene: from a candidate to an established participant in COPD susceptibility
8. MELTEMI and COLUMBA: 5-Year Comparative Safety Analysis of Benralizumab and Mepolizumab
9. Transition of care from adolescence to early adulthood in severe asthmatic patients treated with omalizumab in real-life
10. Trends in Systemic Glucocorticoid Utilization in the United Kingdom from 1990 to 2019: A Population-Based, Serial Cross-Sectional Analysis
11. Severe asthma care trajectories: the French RAMSES cohort
12. Evaluating the Effect of Dupilumab on Type 2 Airway Inflammation and Mucus Plugging in Patients with Uncontrolled Moderate-To-Severe Asthma: the VESTIGE Trial
13. Longitudinal patterns of intermittent oral corticosteroid use for asthma in the UK
14. Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”
15. Long-Term Efficacy Of Dupilumab In Patients With Moderate-To-Severe Type 2 Asthma Stratified By Baseline Characteristics During The 96-Week TRAVERSE Study
16. Efficacy and Safety of Benralizumab Compared with Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis in Patients Receiving Standard of Care Therapy: Phase 3 MANDARA Study
17. CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma
18. Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-asthma Biologics
19. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma
20. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma
21. Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors
22. Multiple Biologics for Multiple T2 Diseases: A Pharmacoepidemiological Algorithm for Sorting Out Patients by Indication
23. Mepolizumab Reduces Systemic Corticosteroid Use in Chronic Rhinosinusitis With Nasal Polyps
24. Arterial Sleeve Lobectomy: Does Pulmonary Artery Reconstruction Type Impact Lung Function?
25. Adult Severe Asthma Registries: A Global and Growing Inventory
26. Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort
27. Early COPD and Hedgehog interacting protein (HHIP) polymorphisms
28. Characteristics of exacerbations in patients with severe, uncontrolled asthma who received tezepelumab versus placebo
29. Late Breaking Abstract - Development of a bronchial epithelium with a sensory innervation both derived from induced pluripotent stem cells
30. Phenotypic characterization of interstitial lung disease associated with mutations in SFTPC and ABCA3 in adults
31. High-dose aspirin in severe uncontrolled asthma associated with chronic rhinosinusitis with nasal polyps (CRwNP) : the ASTHMIRINE trial
32. Benefits of bronchial epithelial repair by iPSC in COPD
33. Blunted vascular response to pulmonary rehabilitation in COPD patients and impaired exercise-induced mobilization of endothelial-colony forming cells
34. Lower respiratory tract involvement in recurrent respiratory papillomatosis in a multicentric cohort study
35. Sputum viscosity is correlated with Computed Tomography (CT) mucus score in muco-obstructive lung diseases
36. An algorithm to identify patients with T2 diseases and Chronic Spontaneous Urticaria treated with biologics in outpatient care setting using a dynamic dispensing database
37. Revisiting Peter Macklem's old dream through the PRISm of lung volumes
38. Elevated Blood Pressure Occurs without Endothelial Dysfunction in a Rat Model of Pulmonary Emphysema
39. The Transcriptome Landscape of the In Vitro Human Airway Epithelium Response to SARS-CoV-2
40. Development and external validation of a prediction model for the transition from mild to moderate or severe form of COVID-19
41. Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective
42. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
43. French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version
44. Dapagliflozin initiation in chronic heart failure patients improves central sleep apnoea
45. What place will tezepelumab hold in the treatment paradigm in chronic rhinosinusitis?
46. Diastolic Cardiomyopathy Secondary to Experimentally Induced Exacerbated Emphysema
47. Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma: the NAVIGATOR study
48. Dose-dependent cardiovascular disorders in a rat model with exacerbated emphysema: Implication of inflammation
49. Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension
50. Human airway ex vivo models: new tools to study the airway epithelial cell response to SARS-CoV-2 infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.